Target intelligence / Profile preview

Ubiquitin-conjugating enzyme pseudogene

Molecular classification
Pseudogene, Processed pseudogene (likely, based on naming conventions—processed pseudogenes arise from reverse-transcribed mRNA and lack introns)
01

Overview

The ubiquitin-conjugating enzyme pseudogene designated by Ensembl as ENSG00000235583 is a non-protein-coding genomic DNA sequence that resembles the active ubiquitin-conjugating enzyme gene but harbors mutations or truncations that disrupt protein production. As a pseudogene, it is classified as either processed or unprocessed, most commonly resulting from reverse-transcribed mRNA reintegrated into the genome without regulatory promoters or protein-coding capability. While formerly considered "junk DNA," some pseudogenes, when transcribed, may influence the expression of functional genes through RNA-based regulatory mechanisms, contribute to genetic diversity, or in rare cases participate in disease processes, especially cancer, via acting as non-coding RNAs. This particular entry is not a functional enzyme, receptor, or a conventional therapeutic target.

02

Biological functions

Potential gene regulation (some transcribed pseudogenes can act as non-coding RNAs, such as competing endogenous RNAs, antisense RNAs, or small interfering RNAs, thus influencing parental gene expression at RNA or chromatin level)Most do not encode functional proteins or direct cellular functions
03

Disease associations

Some pseudogenes, when actively transcribed, are implicated in cancer development, regulation, or as disease biomarkers, but this varies greatly and requires explicit evidence for each individual pseudogeneNo evidence supports a direct role for ENSG00000235583 in disease
04

Biomarkers

In rare cases, certain pseudogenes may be studied as biomarkers for prognosis or disease association, especially in cancer, but no evidence supports this for ENSG00000235583 specifically

Beyond the preview

Go deeper on Ubiquitin-conjugating enzyme pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-conjugating enzyme pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call